Biofrontera- Warrants (27/10/2026) PEG Ratio

The latest PEG ratio for BFRIW is -8.68. That is below the Healthcare sector average of 1.26. Investors often review this figure alongside Biofrontera- Warrants (27/10/2026)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, BFRIW currently prints -8.68 for PEG ratio, while the sector average sits near 1.26. That is roughly 790.5% below the sector mean. Large gaps often invite a closer look at Biofrontera- Warrants (27/10/2026)'s growth, margins, and balance sheet.

A PEG ratio of -8.68 for Biofrontera- Warrants (27/10/2026) is not 'good' or 'bad' on its own. Compare it with the peer average (1.26) and with BFRIW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BFRIW's PEG ratio (-8.68), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Biofrontera- Warrants (27/10/2026)'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.